Kvantra
Kvantra
Log inSign up for Free
Log inSign up for Free
Stock profile

Bio Plus Co., Ltd(099430.KQ)

Country: United States of AmericaSector: HealthcareIndustry: Medical - SpecialtiesExchange: KOE
Watchlist
Sign up to track this stock
P/E TTM
29.0
History
P/E NTM
6.7
Market cap
246.16B
Currency KRW
KvantraRankiN/ANot enough data to calculate KvantraRank
Value79
Quality24
MomentumN/A
Current price
3,730.00+0.27%
Benchmarks

No price history available.

Key financial summary

Financials in KRW
202020212022202320242025TTM2026E
Total revenueKRWm24,36737,41856,71965,04366,41090,896N/AN/A
Operating profitKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Net profitKRWm9,70310,72521,13725,58114,15115,001N/AN/A
EPS reportedKRWLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Capex per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
FCF per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flowKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Net debtKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Book value equityKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Book value per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)KRWLockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in KRW
202020212022202320242025TTM2026E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLocked

Price target estimates

Low estimateLocked
High estimateLocked
Price consensusLocked
Last year average price targetLocked
Current price3,730.00
Return PotentialLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-scoreLockedLockedLocked
Environmental scoreLockedLockedLocked
Social scoreLockedLockedLocked
Governance scoreLockedLockedLocked
Risk ratingLockedLockedLocked

Company overview

Based in Seongnam-si, South Korea, Bio Plus Co., Ltd, established in 2003, is dedicated to the investigation, formulation, production, and commercialization of bio-based items. The company’s diverse offerings include a variety of dermal fillers, such as SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses. Additionally, Bio Plus manufactures critical medical products: InterBlock, an absorbable anti-adhesion barrier; Synofil, utilized for synovial fluid replacement; and Blad-Care, a treatment for temporary alleviation of cystitis discomfort. Its mesotherapy portfolio features Kiara Reju for skin revitalization, Slim Slimmer for lipolysis, LumiDew for skin brightening, and JuveniHill for addressing wrinkles. The firm also supplies hair and scalp wellness products under the BelloHa and BellaChe names. Rounding out its extensive catalog are La Bella brand cosmetics, which include heparinoid essence, EGF balls, and specialized skin care gels.

SectorHealthcare
IndustryMedical - Specialties
CountryUnited States of America
Trades inKRW

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Bio Plus Co., Ltd (099430.KQ)

099430.KQ · KOE · Healthcare
3,730.00+0.27%
Sign up to track this stock

No price history available.

KvantraRankN/A
P/E TTM29.0
P/E NTM6.7
Market cap246.16B
KvantraRank

Not enough data to calculate KvantraRank

Financialsin KRW
20242025TTM2026E
Analyst target
ConsensusLocked
Current3,730.00
UpsideLocked
LockedLocked
Price consensusLocked
Last year average price targetLocked
Current price3,730.00
Return PotentialLocked

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-scoreLockedLockedLocked
Environmental scoreLockedLockedLocked
Social scoreLockedLockedLocked
Governance scoreLockedLockedLocked
Risk ratingLockedLockedLocked
About

Based in Seongnam-si, South Korea, Bio Plus Co., Ltd, established in 2003, is dedicated to the investigation, formulation, production, and commercialization of bio-based items. The company’s diverse offerings include a variety of dermal fillers, such as SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses. Additionally, Bio Plus manufactures critical medical products: InterBlock, an absorbable anti-adhesion barrier; Synofil, utilized for synovial fluid replacement; and Blad-Care, a treatment for temporary alleviation of cystitis discomfort. Its mesotherapy portfolio features Kiara Reju for skin revitalization, Slim Slimmer for lipolysis, LumiDew for skin brightening, and JuveniHill for addressing wrinkles. The firm also supplies hair and scalp wellness products under the BelloHa and BellaChe names. Rounding out its extensive catalog are La Bella brand cosmetics, which include heparinoid essence, EGF balls, and specialized skin care gels.

SectorHealthcare
IndustryMedical - Specialties
CountryUnited States of America
Trades inKRW
Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans